Chronic hepatitis B virus (HBV) infection can lead to substantial morbidity and mortality.
Although treatment is not considered curative, antiviral treatment, monitoring, and liver …

Chronic hepatitis B virus infection (HBV) continues to pose a serious global health threat in
many areas of the world, particularly in sub-Saharan Africa, the Western Pacific Region and …

Abstract Introduction In 2016, the Global Health Sector Strategy (GHSS) on viral hepatitis
called for elimination of viral hepatitis as a major public health threat by 2030 (ie 90 …

Summary Background The World Health Assembly calls for elimination of viral hepatitis as a
public health threat by 2030 (ie,− 90% incidence and− 65% mortality). However, WHO's …

Background: Vaccination, screening, and linkage to care can reduce the burden of chronic
hepatitis B virus (HBV) infection. However, recommendations vary among organizations …

Importance An estimated 862 000 persons in the US are living with chronic infection with
hepatitis B virus (HBV). Persons born in regions with a prevalence of HBV infection of 2% or …

Background According to death certificates, approximately 1800 persons die from hepatitis B
annually in the United States; however, this figure may underestimate true mortality from …

Background and Aims Hepatitis B virus (HBV) infection continues to threaten millions of lives
across the globe, despite universal vaccination efforts. Current guidelines for screening …

Abstract Background & Aims There is limited knowledge about hepatitis B virus (HBV) flare
among pregnant women. We evaluated the incidence, determinants and outcomes of HBV …

Coinfection with human immunodeficiency virus (HIV) and viral hepatitis is associated with
high morbidity and mortality in the absence of clinical management, making identification of …